NZ531700A - 1-Glyoxylamide indolizines for treating cancer - Google Patents
1-Glyoxylamide indolizines for treating cancerInfo
- Publication number
- NZ531700A NZ531700A NZ531700A NZ53170002A NZ531700A NZ 531700 A NZ531700 A NZ 531700A NZ 531700 A NZ531700 A NZ 531700A NZ 53170002 A NZ53170002 A NZ 53170002A NZ 531700 A NZ531700 A NZ 531700A
- Authority
- NZ
- New Zealand
- Prior art keywords
- substituted
- group
- alkyl
- unsubstituted
- ring
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32202001P | 2001-09-13 | 2001-09-13 | |
| PCT/US2002/029154 WO2003022846A1 (en) | 2001-09-13 | 2002-09-13 | 1-glyoxlylamide indolizines for treating cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ531700A true NZ531700A (en) | 2006-10-27 |
Family
ID=23253054
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ531700A NZ531700A (en) | 2001-09-13 | 2002-09-13 | 1-Glyoxylamide indolizines for treating cancer |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US6861436B2 (OSRAM) |
| EP (1) | EP1432709B8 (OSRAM) |
| JP (1) | JP2005504795A (OSRAM) |
| KR (1) | KR20040053125A (OSRAM) |
| CN (1) | CN1568324A (OSRAM) |
| AT (1) | ATE300542T1 (OSRAM) |
| AU (1) | AU2002333626B2 (OSRAM) |
| BR (1) | BR0212794A (OSRAM) |
| CA (1) | CA2459886A1 (OSRAM) |
| DE (1) | DE60205265T2 (OSRAM) |
| ES (1) | ES2245747T3 (OSRAM) |
| IL (1) | IL160810A0 (OSRAM) |
| IS (1) | IS7176A (OSRAM) |
| MX (1) | MXPA04002323A (OSRAM) |
| NO (1) | NO20041035L (OSRAM) |
| NZ (1) | NZ531700A (OSRAM) |
| PT (1) | PT1432709E (OSRAM) |
| WO (1) | WO2003022846A1 (OSRAM) |
| ZA (1) | ZA200401996B (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040116462A1 (en) * | 2002-12-12 | 2004-06-17 | Mitsunori Ono | Indolizine compounds |
| MXPA04002323A (es) * | 2001-09-13 | 2005-04-08 | Synta Pharmaceuticals Corp | 1-GLIOXILILAMIDA-INDOLIZINAS PARA EL TRATAMIENTO DEL CáNCER. |
| CN1681813A (zh) * | 2002-09-13 | 2005-10-12 | 辛塔医药品有限公司 | 中氮茚的合成 |
| DE10318611A1 (de) | 2003-04-24 | 2004-11-11 | Elbion Ag | 4-, 6- oder 7-Hydroxyindole mit N-Oxidgruppen und deren Verwendung als Therapeutika |
| WO2005099824A1 (en) * | 2004-03-30 | 2005-10-27 | Synta Pharmaceuticals, Corp. | 1-glyoxylamide indolizines for treating lung and ovarian cancer |
| GB0413605D0 (en) | 2004-06-17 | 2004-07-21 | Addex Pharmaceuticals Sa | Novel compounds |
| US20070293456A9 (en) * | 2004-12-30 | 2007-12-20 | Anthony Hayford | Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds |
| US20070155738A1 (en) | 2005-05-20 | 2007-07-05 | Alantos Pharmaceuticals, Inc. | Heterobicyclic metalloprotease inhibitors |
| AU2006251989B2 (en) * | 2005-05-20 | 2010-05-27 | Alantos-Pharmaceuticals, Inc. | Pyrimidine or triazine fused bicyclic metalloprotease inhibitors |
| CA2733247C (en) * | 2008-08-14 | 2018-04-03 | Beta Pharma Canada Inc. | Heterocyclic amide derivatives as ep4 receptor antagonists |
| NZ720946A (en) | 2009-04-29 | 2017-09-29 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| AR077428A1 (es) * | 2009-07-29 | 2011-08-24 | Sanofi Aventis | (aza) indolizinacarboxamidas ciclicas su preparacion y su uso como agentes farmaceuticos |
| CN113603694B (zh) * | 2021-07-16 | 2022-07-22 | 浙江工业大学 | 一种1,2-二酮类化合物及其制备方法和应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2287706A (en) | 1994-03-21 | 1995-09-27 | Fujisawa Pharmaceutical Co | Indolizine derivatives |
| FR2757166B1 (fr) * | 1996-12-12 | 1999-01-29 | Rhone Poulenc Rorer Sa | Derives du pyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent |
| WO1998047507A1 (en) | 1997-04-24 | 1998-10-29 | Shionogi & Co., Ltd. | Method for the treatment of stroke using n-heterocyclic glyoxylamide compounds |
| US6472389B1 (en) | 1998-05-21 | 2002-10-29 | Shionogi & Co., Ltd. | Pyrrolo[1,2-b] pyridazine derivatives having sPLA2 inhibitory effect |
| AU6004799A (en) | 1998-10-14 | 2000-05-01 | Shionogi & Co., Ltd. | Remedies or preventives for ischemic reflow failure |
| US6461538B2 (en) * | 1999-12-16 | 2002-10-08 | Fuji Photo Film Co., Ltd. | Production process for indolizine compounds and their use in organic light-emitting devices |
| MXPA04002323A (es) * | 2001-09-13 | 2005-04-08 | Synta Pharmaceuticals Corp | 1-GLIOXILILAMIDA-INDOLIZINAS PARA EL TRATAMIENTO DEL CáNCER. |
| US20040116462A1 (en) * | 2002-12-12 | 2004-06-17 | Mitsunori Ono | Indolizine compounds |
-
2002
- 2002-09-13 MX MXPA04002323A patent/MXPA04002323A/es unknown
- 2002-09-13 WO PCT/US2002/029154 patent/WO2003022846A1/en not_active Ceased
- 2002-09-13 NZ NZ531700A patent/NZ531700A/en unknown
- 2002-09-13 ES ES02798231T patent/ES2245747T3/es not_active Expired - Lifetime
- 2002-09-13 AU AU2002333626A patent/AU2002333626B2/en not_active Ceased
- 2002-09-13 PT PT02798231T patent/PT1432709E/pt unknown
- 2002-09-13 KR KR10-2004-7003754A patent/KR20040053125A/ko not_active Withdrawn
- 2002-09-13 IL IL16081002A patent/IL160810A0/xx unknown
- 2002-09-13 DE DE60205265T patent/DE60205265T2/de not_active Expired - Fee Related
- 2002-09-13 AT AT02798231T patent/ATE300542T1/de not_active IP Right Cessation
- 2002-09-13 US US10/244,088 patent/US6861436B2/en not_active Expired - Fee Related
- 2002-09-13 EP EP02798231A patent/EP1432709B8/en not_active Expired - Lifetime
- 2002-09-13 JP JP2003526921A patent/JP2005504795A/ja active Pending
- 2002-09-13 CN CNA028202848A patent/CN1568324A/zh active Pending
- 2002-09-13 CA CA002459886A patent/CA2459886A1/en not_active Abandoned
- 2002-09-13 BR BR0212794-6A patent/BR0212794A/pt not_active IP Right Cessation
-
2004
- 2004-03-11 NO NO20041035A patent/NO20041035L/no not_active Application Discontinuation
- 2004-03-11 IS IS7176A patent/IS7176A/is unknown
- 2004-03-11 ZA ZA200401996A patent/ZA200401996B/xx unknown
- 2004-05-20 US US10/849,978 patent/US20040214850A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE60205265T2 (de) | 2006-03-30 |
| BR0212794A (pt) | 2004-10-05 |
| ZA200401996B (en) | 2005-05-31 |
| EP1432709B1 (en) | 2005-07-27 |
| EP1432709A1 (en) | 2004-06-30 |
| ES2245747T3 (es) | 2006-01-16 |
| US20030153759A1 (en) | 2003-08-14 |
| JP2005504795A (ja) | 2005-02-17 |
| AU2002333626B2 (en) | 2006-06-29 |
| CA2459886A1 (en) | 2003-03-20 |
| NO20041035L (no) | 2004-04-30 |
| IL160810A0 (en) | 2004-08-31 |
| DE60205265D1 (de) | 2005-09-01 |
| HK1063322A1 (en) | 2004-12-24 |
| WO2003022846A1 (en) | 2003-03-20 |
| CN1568324A (zh) | 2005-01-19 |
| KR20040053125A (ko) | 2004-06-23 |
| US20040214850A1 (en) | 2004-10-28 |
| IS7176A (is) | 2004-03-11 |
| PT1432709E (pt) | 2005-10-31 |
| ATE300542T1 (de) | 2005-08-15 |
| EP1432709B8 (en) | 2005-11-02 |
| US6861436B2 (en) | 2005-03-01 |
| MXPA04002323A (es) | 2005-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002323475B2 (en) | 2-aroylimidazole compounds for treating cancer | |
| JP5700837B2 (ja) | Ｎａｄｐｈオキシダーゼインヒビターとしてのピラゾロピリジン誘導体 | |
| JP2022153616A (ja) | Ｓｈｐ２阻害剤として有用な新規複素環式誘導体 | |
| AU2002323475A1 (en) | 2-aroylimidazole compounds for treating cancer | |
| CN108024971A (zh) | 作为irak-4抑制剂的取代的氮杂化合物 | |
| WO2007032466A1 (ja) | 複素環化合物、その製造方法並びに用途 | |
| NZ522732A (en) | Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors | |
| NZ531700A (en) | 1-Glyoxylamide indolizines for treating cancer | |
| JP2011510004A (ja) | タンパク質キナーゼ阻害剤及びその使用 | |
| AU2002323474B2 (en) | 3-glyoxlylamideindoles for treating cancer | |
| JP2020502066A (ja) | キナーゼ阻害剤としての複素環式化合物 | |
| AU2002333626A1 (en) | 1-glyoxlylamide indolizines for treating cancer | |
| CA3257946A1 (en) | PI3K INHIBITOR, ASSOCIATED PREPARATION PROCESS AND ASSOCIATED USE | |
| AU2002323474A1 (en) | 3-glyoxlylamideindoles for treating cancer | |
| CN107880038B (zh) | [1,2,4]三唑并[1,5-a]吡啶类化合物及其制备方法和医药用途 | |
| CN111269215B (zh) | 含氮杂环有机化合物及其制备方法和应用 | |
| EP1598352A1 (en) | 1-Glyoxylamide indolizines for treating cancer | |
| HK1063322B (en) | 1-glyoxylamide indolizines for treating cancer | |
| HK1079507A (en) | 1-glyoxylamide indolizines for treating cancer | |
| CN111072667A (zh) | 五元或六元杂环并嘧啶类化合物及其用途 | |
| WO2023168908A1 (zh) | 稠合的醌肟咪唑及其鎓衍生物与其制备和用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed |